Literature DB >> 33147422

Concurrent Reductions in Spirometry Predict Mortality and Bronchiolitis Obliterans in Chronic Graft-versus-Host Disease.

David N O'Dwyer1, Yizhuo Wang2, Dawson Myers1, Bethany B Moore1, Susan Murray2, Gregory A Yanik1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 33147422      PMCID： PMC8009010          DOI： 10.1513/AnnalsATS.202008-999RL

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN： 2325-6621


× No keyword cloud information.
  13 in total

1.  Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis.

Authors:  Harold R Collard; Talmadge E King; Becki Bucher Bartelson; Jason S Vourlekis; Marvin I Schwarz; Kevin K Brown
Journal:  Am J Respir Crit Care Med       Date:  2003-05-28       Impact factor: 21.405

2.  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report.

Authors:  Madan H Jagasia; Hildegard T Greinix; Mukta Arora; Kirsten M Williams; Daniel Wolff; Edward W Cowen; Jeanne Palmer; Daniel Weisdorf; Nathaniel S Treister; Guang-Shing Cheng; Holly Kerr; Pamela Stratton; Rafael F Duarte; George B McDonald; Yoshihiro Inamoto; Afonso Vigorito; Sally Arai; Manuel B Datiles; David Jacobsohn; Theo Heller; Carrie L Kitko; Sandra A Mitchell; Paul J Martin; Howard Shulman; Roy S Wu; Corey S Cutler; Georgia B Vogelsang; Stephanie J Lee; Steven Z Pavletic; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-18       Impact factor: 5.742

3.  Bronchiolitis obliterans syndrome epidemiology after allogeneic hematopoietic cell transplantation.

Authors:  Brandon K C Au; Margaret A Au; Jason W Chien
Journal:  Biol Blood Marrow Transplant       Date:  2010-11-30       Impact factor: 5.742

4.  Longitudinal Forced Vital Capacity Monitoring as a Prognostic Adjunct after Lung Transplantation.

Authors:  Elizabeth A Belloli; Xin Wang; Susan Murray; Ginia Forrester; Adrian Weyhing; Jules Lin; Tammy Ojo; Vibha N Lama
Journal:  Am J Respir Crit Care Med       Date:  2015-07-15       Impact factor: 21.405

5.  Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction.

Authors:  Jamie L Todd; Rahil Jain; Elizabeth N Pavlisko; C Ashley Finlen Copeland; John M Reynolds; Laurie D Snyder; Scott M Palmer
Journal:  Am J Respir Crit Care Med       Date:  2014-01-15       Impact factor: 21.405

6.  Airflow obstruction after myeloablative allogeneic hematopoietic stem cell transplantation.

Authors:  Jason W Chien; Paul J Martin; Ted A Gooley; Mary E Flowers; Susan R Heckbert; W Garrett Nichols; Joan G Clark
Journal:  Am J Respir Crit Care Med       Date:  2003-03-20       Impact factor: 21.405

7.  Bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation.

Authors:  Kirsten M Williams; Jason W Chien; Mark T Gladwin; Steven Z Pavletic
Journal:  JAMA       Date:  2009-07-15       Impact factor: 56.272

8.  Rapid versus gradual lung function decline in bronchiolitis obliterans syndrome after haematopoietic stem cell transplantation is associated with survival outcome.

Authors:  Wang-Chun Kwok; Bin-Miao Liang; Macy M S Lui; Terence C C Tam; Joycelyn P Y Sim; Eric W C Tse; Anskar Y H Leung; Yok L Kwong; Albert K W Lie; Mary S M Ip; David C L Lam
Journal:  Respirology       Date:  2019-01-20       Impact factor: 6.424

9.  Abnormalities of pulmonary function tests after marrow transplantation predict nonrelapse mortality.

Authors:  S W Crawford; M Pepe; D Lin; F Benedetti; H J Deeg
Journal:  Am J Respir Crit Care Med       Date:  1995-08       Impact factor: 21.405

10.  Impact of Lung Function on Bronchiolitis Obliterans Syndrome and Outcome after Allogeneic Hematopoietic Cell Transplantation with Reduced-Intensity Conditioning.

Authors:  Jesús Duque-Afonso; Gabriele Ihorst; Miguel Waterhouse; Robert Zeiser; Ralph Wäsch; Hartmut Bertz; Joachim Müller-Quernheim; Jürgen Finke; Reinhard Marks; Antje Prasse
Journal:  Biol Blood Marrow Transplant       Date:  2018-06-28       Impact factor: 5.742
View more
  1 in total

Review 1.  Airway disease in hematologic malignancies.

Authors:  Ricardo J José; Burton F Dickey; Ajay Sheshadri
Journal:  Expert Rev Respir Med       Date:  2022-02-21       Impact factor: 4.300
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.